BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics
01 September 2020
The BEAM Alliance and the co-signatories of this paper urge the EU and its Member States to urgently act and fix the broken economics around investment into the development and commercialization of antimicrobials.
Further reading: BEAM Alliance
Author(s): BEAM Alliance
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
